逆流检测产品市场 - 全球产业规模、份额、趋势、机会、预测：按产品类型、疾病征兆、最终用户、地区和竞争格局划分，2021-2031年

全球回流测试产品市场预计将从 2025 年的 37.2 亿美元成长到 2031 年的 50.1 亿美元，复合年增长率为 5.09%。

此领域涵盖多种用于测量和识别胃内容物食道逆流的诊断工具，例如食道测压系统、基于导管的电阻-pH监测仪和无线pH胶囊。推动这一领域发展的主要动力是全球胃食道逆流症（GERD）盛行率的不断上升。准确客观的检验对于GERD的诊断和有效的手术方案製定至关重要。此外，人口老化和肥胖率的上升也扩大了易患慢性酸性逆流的人群，这需要进行全面的诊断评估，并进一步刺激了市场发展。

然而，传统导管监测带来的不适感和病患依从性差是重要的障碍，导致病患犹豫是否接受必要的检查。这个问题凸显了诊断需求与患者耐受程度之间的矛盾。根据国际食道疾病学会2025年报告，全球胃食道逆流（GERD）病例预计将增加至约8.26亿例，这一数字凸显了高效反流检测解决方案的迫切需求。

市场驱动因素

巴瑞特氏食道症和食道腺癌发生率的上升凸显了精准逆流检测的迫切需求，使其成为一项重要的临床挑战。由于慢性胃食道逆流会损伤食道黏膜，因此透过严格的电阻和pH监测筛检癌前细胞变化至关重要。这种迫切性正促使检测从简单的症状管理转变为预防肿瘤学的关键要求。根据美国癌症协会于2024年1月发布的《2024年癌症事实与数据》，预计美国将新增22,370例食道癌病例，这进一步强调了利用先进诊断设备进行早期检测的必要性。

同时，无线pH监测技术的快速发展正在改变这一领域，解决了导管系统通用的依从性问题。这些先进的胶囊式设备能够实现长期数据记录，且不会造成身体不适，使临床医生能够获得客观的逆流证据。这项技术进步也体现在主要企业的财务表现中。例如，美敦力公司于2024年5月发布的2024年第四季财报显示，其医疗外科产品组合的全球销售额达到22亿美元，凸显了该领域的商业性规模。此外，肥胖率的上升加剧了逆流症状，也推动了市场的发展。世界卫生组织（WHO）2024年的报告显示，全球有超过10亿人肥胖，这是一个庞大的群体，需要长期的诊断解决方案。

市场挑战

标准导管监测带来的不适感和低依从性是阻碍全球逆流检测产品市场收入成长的主要障碍。电阻-pH监测和食道测压等检查通常需要插入鼻胃管，这往往会引起噁心反射、焦虑和明显的身体不适。这种侵入性操作在治疗过程中造成了极大的阻力，导致许多合格的患者拒绝接受确诊性检查或在治疗过程中途放弃。因此，医疗服务提供者往往更依赖经验性治疗而非客观诊断，从而减少了检测设备的使用，并阻碍了市场渗透。

这种阻力构成了一个特定的瓶颈，阻碍了市场充分利用胃肠道疾病日益普遍的趋势。根据美国胃肠病学会的报告，到2024年，超过30%的美国成年人每週至少会出现一次胃食道逆流症的症状。这项统计数据表明，由于传统导管诊断通讯协定固有的耐受性问题，大量潜在患者群体未能获得足够的诊断产品治疗。

市场趋势

将人工智慧 (AI) 整合到反流资料分析中，正在变革诊断软体，使其从基础指标发展到自动化模式识别。传统的追踪方法会产生大量资料集，这可能导致在人工检查中遗漏一些细微的变化，例如非酸性逆流发作。如今，人工智慧演算法能够高精度地识别这些异常情况，从而辅助临床医生，降低观察者间的差异，并提高复杂病例的诊断准确性。这项技术进步得到了强有力的临床证据支持。发表于 2024 年 7 月《JMIR 医学资讯学》杂誌的一项题为「人工智慧在内视镜诊断中的准确性：一项综合综述」的研究报告称，人工智慧模型在诊断胃食道逆流疾病方面达到了 97% 的敏感性，显着优于标准的人工方法。

由于标准的24小时通讯协定常常遗漏常规症状的波动，临床上正朝着多日、长期携带式监测的方向发展，以应对这项挑战。医生越来越依赖长达96小时的无线监测，以便在诊断不明确的病例中可靠地识别病理性酸暴露，而不是依赖短期观察。这项转变基于以下证据：更长的监测时间能够显着提高对可能被漏诊的合格患者的识别率。根据美国胃肠病学会2024年9月发布的题为「长期无线pH监测与24小时电阻电阻监测的诊断率比较」的研究，长期无线监测对胃食道逆流（GERD）的明确诊断率达到50%，而传统的24小时阻抗监测仅为27%。

目录

第一章概述

第二章：调查方法

第三章执行摘要

第四章：客户心声

第五章：全球回流检测产品市场展望

• 市场规模及预测
  • 按金额
• 市占率及预测
  • 产品类型（导管式诊断产品、胶囊式诊断产品、逆流检测探针、其他）
  • 按类型分類的疾病征兆（巴瑞特氏食道症、逆流性食道炎、食道腺癌）
  • 依最终使用者（医院/诊所、门诊手术中心、其他）划分
  • 按地区
  • 按公司（2025 年）
• 市场地图

第六章：北美逆流检测产品市场展望

• 市场规模及预测
• 市占率及预测
• 北美洲：国别分析
  • 我们
  • 加拿大
  • 墨西哥

第七章：欧洲回流检测产品市场展望

• 市场规模及预测
• 市占率及预测
• 欧洲：国别分析
  • 德国
  • 法国
  • 英国
  • 义大利
  • 西班牙

第八章：亚太地区回流检测产品市场展望

• 市场规模及预测
• 市占率及预测
• 亚太地区：国别分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

第九章：中东和非洲回流检测产品市场展望

• 市场规模及预测
• 市占率及预测
• 中东与非洲：国别分析
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 南非

第十章：南美回流检测产品市场展望

• 市场规模及预测
• 市占率及预测
• 南美洲：国别分析
  • 巴西
  • 哥伦比亚
  • 阿根廷

第十一章 市场动态

• 促进因素
• 任务

第十二章 市场趋势与发展

• 併购
• 产品发布
• 近期趋势

第十三章：全球回流检测产品市场：SWOT分析

第十四章：波特五力分析

• 产业竞争
• 新进入者的潜力
• 供应商的议价能力
• 顾客权力
• 替代品的威胁

第十五章 竞争格局

• Medtronic Plc
• Sierra Instruments, Inc.
• Respiratory Technology Corporation
• Ethicon, Inc.
• Medical Measurement Systems BV
• AstraZeneca Plc
• Diversatek, Inc.
• FLSmidth A/S
• Laborie Medical Technologies Corp.
• DRG Instruments GmbH

第十六章 策略建议

第十七章：关于研究公司及免责声明

The Global Reflux Testing Products Market is projected to expand from USD 3.72 Billion in 2025 to USD 5.01 Billion by 2031, registering a compound annual growth rate of 5.09%. This sector includes various diagnostic tools such as esophageal manometry systems, catheter-based impedance-pH monitors, and wireless pH capsules, all utilized to measure and identify the regurgitation of stomach contents into the esophagus. A major force driving this expansion is the increasing global prevalence of gastroesophageal reflux disease (GERD), which requires precise objective verification to diagnose conditions and plan surgeries effectively. Additionally, the growing number of aging individuals and rising obesity rates further fuel the market by enlarging the population susceptible to chronic acid reflux, necessitating thorough diagnostic assessments.

However, the industry encounters a notable obstacle due to the discomfort and non-compliance linked to conventional catheter-based monitoring, which discourages patients from proceeding with essential tests. This issue underscores the conflict between the need for diagnosis and what patients are willing to endure. As reported by the International Society for Diseases of the Esophagus in 2025, the global burden of GERD has escalated to roughly 826 million cases, a figure that emphasizes the urgent and expanding need for efficient reflux testing solutions.

Market Driver

The rising incidence of Barrett's esophagus and esophageal adenocarcinoma acts as a vital clinical imperative driving the need for accurate reflux testing. Because chronic gastroesophageal reflux harms the esophageal lining, screening for pre-cancerous cellular changes through rigorous impedance and pH monitoring is essential. This urgency transforms testing from simple symptom management into a critical requirement for preventative oncology. As stated by the American Cancer Society in their January 2024 'Cancer Facts & Figures 2024', an estimated 22,370 new esophageal cancer cases were projected for the United States, reinforcing the necessity for early identification via advanced diagnostic instruments.

Simultaneously, rapid progress in wireless pH monitoring is transforming the sector by addressing the compliance issues common with catheter-based systems. These modern capsule devices enable extended data recording without causing physical distress, thereby encouraging clinicians to rely on objective evidence of reflux. This technological evolution is mirrored in the financial results of leading companies; for instance, Medtronic's 'Fourth Quarter Fiscal 2024 Financial Results' from May 2024 showed their Medical Surgical Portfolio generated $2.2 billion in worldwide revenue, underscoring the segment's commercial magnitude. Furthermore, the market is supported by growing obesity rates that worsen reflux symptoms, with the World Health Organization reporting in 2024 that over 1 billion individuals globally are living with obesity, creating a massive demographic in need of long-term diagnostic solutions.

Market Challenge

The discomfort and lack of compliance associated with standard catheter-based monitoring represent a significant hurdle that directly restricts revenue growth in the Global Reflux Testing Products Market. Procedures like impedance-pH monitoring and esophageal manometry generally involve the transnasal insertion of a catheter, which often triggers gagging, anxiety, and substantial physical irritation. This invasive aspect causes considerable friction during care, leading many eligible patients to decline confirmatory tests or end procedures prematurely. As a result, medical providers frequently resort to empirical medication rather than insisting on objective diagnostics, thereby diminishing the usage of testing devices and curbing market penetration.

This reluctance forms a specific bottleneck that hampers the market's ability to fully benefit from the increasing prevalence of digestive conditions. According to the American Gastroenterological Association, over 30% of adults in the United States reported experiencing symptoms of gastroesophageal reflux disease on at least a weekly basis in 2024. This statistic indicates a vast addressable patient group that remains underserved by diagnostic products largely because of the tolerability challenges embedded in conventional catheter-based protocols.

Market Trends

The integration of Artificial Intelligence into reflux data analysis is transforming diagnostic software by evolving from basic metrics to automated pattern recognition. Traditional tracings produce extensive datasets where minor variations, such as non-acid reflux episodes, might be missed during manual examination. AI algorithms now support clinicians by pinpointing these anomalies with great accuracy, reducing variability between observers and boosting diagnostic certainty in difficult cases. This technological advancement is backed by strong clinical evidence; a study in JMIR Medical Informatics titled 'Diagnostic Accuracy of Artificial Intelligence in Endoscopy: Umbrella Review' from July 2024 noted that AI models achieved a sensitivity of 97% in diagnosing gastroesophageal reflux disease, significantly surpassing standard manual methods.

The shift toward prolonged multi-day ambulatory monitoring marks a clinical progression designed to resolve the shortcomings of standard 24-hour protocols, which frequently miss daily symptom fluctuations. Physicians are increasingly favoring extended wireless monitoring periods lasting up to 96 hours to conclusively identify pathologic acid exposure in unclear cases, rather than depending on shorter observation windows. This change is motivated by evidence showing that longer testing durations considerably improve the identification of eligible patients who might otherwise be overlooked. According to the American College of Gastroenterology's September 2024 study 'Diagnostic Yield of Prolonged Wireless pH vs 24-hour pH-Impedance Monitoring', the diagnostic yield for confirming gastroesophageal reflux disease reached 50% with prolonged wireless monitoring, compared to just 27% using traditional 24-hour impedance monitoring.

Key Market Players

• Medtronic Plc
• Sierra Instruments, Inc.
• Respiratory Technology Corporation
• Ethicon, Inc.
• Medical Measurement Systems BV
• AstraZeneca Plc
• Diversatek, Inc.
• FLSmidth A/S
• Laborie Medical Technologies Corp.
• DRG Instruments GmbH

Report Scope

In this report, the Global Reflux Testing Products Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Reflux Testing Products Market, By Product Type

• Catheter Based Testing Products
• Capsule Based Testing Products
• Reflux Testing Probes
• Others

Reflux Testing Products Market, By Disease Indication

• Barrett's Esophagus
• Reflux Esophagitis
• Esophageal Adenocarcinoma

Reflux Testing Products Market, By End User

• Hospitals &Clinics
• Ambulatory Surgical Centers
• Others

Reflux Testing Products Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Reflux Testing Products Market.

Available Customizations:

Global Reflux Testing Products Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Reflux Testing Products Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product Type (Catheter Based Testing Products, Capsule Based Testing Products, Reflux Testing Probes, Others)
  • 5.2.2. By Disease Indication (Barrett's Esophagus, Reflux Esophagitis, Esophageal Adenocarcinoma)
  • 5.2.3. By End User (Hospitals &Clinics, Ambulatory Surgical Centers, Others)
  • 5.2.4. By Region
  • 5.2.5. By Company (2025)
• 5.3. Market Map

6. North America Reflux Testing Products Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product Type
  • 6.2.2. By Disease Indication
  • 6.2.3. By End User
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Reflux Testing Products Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product Type
      • 6.3.1.2.2. By Disease Indication
      • 6.3.1.2.3. By End User
  • 6.3.2. Canada Reflux Testing Products Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product Type
      • 6.3.2.2.2. By Disease Indication
      • 6.3.2.2.3. By End User
  • 6.3.3. Mexico Reflux Testing Products Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product Type
      • 6.3.3.2.2. By Disease Indication
      • 6.3.3.2.3. By End User

7. Europe Reflux Testing Products Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product Type
  • 7.2.2. By Disease Indication
  • 7.2.3. By End User
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Reflux Testing Products Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product Type
      • 7.3.1.2.2. By Disease Indication
      • 7.3.1.2.3. By End User
  • 7.3.2. France Reflux Testing Products Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product Type
      • 7.3.2.2.2. By Disease Indication
      • 7.3.2.2.3. By End User
  • 7.3.3. United Kingdom Reflux Testing Products Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product Type
      • 7.3.3.2.2. By Disease Indication
      • 7.3.3.2.3. By End User
  • 7.3.4. Italy Reflux Testing Products Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product Type
      • 7.3.4.2.2. By Disease Indication
      • 7.3.4.2.3. By End User
  • 7.3.5. Spain Reflux Testing Products Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product Type
      • 7.3.5.2.2. By Disease Indication
      • 7.3.5.2.3. By End User

8. Asia Pacific Reflux Testing Products Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product Type
  • 8.2.2. By Disease Indication
  • 8.2.3. By End User
  • 8.2.4. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Reflux Testing Products Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product Type
      • 8.3.1.2.2. By Disease Indication
      • 8.3.1.2.3. By End User
  • 8.3.2. India Reflux Testing Products Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product Type
      • 8.3.2.2.2. By Disease Indication
      • 8.3.2.2.3. By End User
  • 8.3.3. Japan Reflux Testing Products Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product Type
      • 8.3.3.2.2. By Disease Indication
      • 8.3.3.2.3. By End User
  • 8.3.4. South Korea Reflux Testing Products Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product Type
      • 8.3.4.2.2. By Disease Indication
      • 8.3.4.2.3. By End User
  • 8.3.5. Australia Reflux Testing Products Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product Type
      • 8.3.5.2.2. By Disease Indication
      • 8.3.5.2.3. By End User

9. Middle East & Africa Reflux Testing Products Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product Type
  • 9.2.2. By Disease Indication
  • 9.2.3. By End User
  • 9.2.4. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Reflux Testing Products Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product Type
      • 9.3.1.2.2. By Disease Indication
      • 9.3.1.2.3. By End User
  • 9.3.2. UAE Reflux Testing Products Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product Type
      • 9.3.2.2.2. By Disease Indication
      • 9.3.2.2.3. By End User
  • 9.3.3. South Africa Reflux Testing Products Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product Type
      • 9.3.3.2.2. By Disease Indication
      • 9.3.3.2.3. By End User

10. South America Reflux Testing Products Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product Type
  • 10.2.2. By Disease Indication
  • 10.2.3. By End User
  • 10.2.4. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Reflux Testing Products Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product Type
      • 10.3.1.2.2. By Disease Indication
      • 10.3.1.2.3. By End User
  • 10.3.2. Colombia Reflux Testing Products Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product Type
      • 10.3.2.2.2. By Disease Indication
      • 10.3.2.2.3. By End User
  • 10.3.3. Argentina Reflux Testing Products Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product Type
      • 10.3.3.2.2. By Disease Indication
      • 10.3.3.2.3. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Reflux Testing Products Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Medtronic Plc
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Sierra Instruments, Inc.
• 15.3. Respiratory Technology Corporation
• 15.4. Ethicon, Inc.
• 15.5. Medical Measurement Systems BV
• 15.6. AstraZeneca Plc
• 15.7. Diversatek, Inc.
• 15.8. FLSmidth A/S
• 15.9. Laborie Medical Technologies Corp.
• 15.10. DRG Instruments GmbH

16. Strategic Recommendations

17. About Us & Disclaimer